These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23102107)

  • 1. Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy.
    Rachagani S; Torres MP; Kumar S; Haridas D; Baine M; Macha MA; Kaur S; Ponnusamy MP; Dey P; Seshacharyulu P; Johansson SL; Jain M; Wagner KU; Batra SK
    J Hematol Oncol; 2012 Oct; 5():68. PubMed ID: 23102107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acinar transformed ductal cells exhibit differential mucin expression in a tamoxifen-induced pancreatic ductal adenocarcinoma mouse model.
    Mallya K; Haridas D; Seshacharyulu P; Pothuraju R; Junker WM; Krishn SR; Muniyan S; Vengoji R; Batra SK; Rachagani S
    Biol Open; 2020 Sep; 9(9):. PubMed ID: 32709695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of MUC3 and MUC4 membrane-associated mucins and sialyl Le(x) antigen in pancreatic intraepithelial neoplasia.
    Park HU; Kim JW; Kim GE; Bae HI; Crawley SC; Yang SC; Gum JR; Batra SK; Rousseau K; Swallow DM; Sleisenger MH; Kim YS
    Pancreas; 2003 Apr; 26(3):e48-54. PubMed ID: 12657964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer.
    Kumar S; Das S; Rachagani S; Kaur S; Joshi S; Johansson SL; Ponnusamy MP; Jain M; Batra SK
    Oncogene; 2015 Sep; 34(37):4879-89. PubMed ID: 25531332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of MUC1 and MUC5AC mRNA in pancreatic juice for preoperative diagnosis of pancreatic cancer.
    Ohuchida K; Mizumoto K; Yamada D; Fujii K; Ishikawa N; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Int J Cancer; 2006 Jan; 118(2):405-11. PubMed ID: 16052519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and feasibility of mucin expression profiling by qRT-PCR as diagnostic biomarkers in cytology specimens of pancreatic cancer.
    Wiktorowicz M; Mlynarski D; Pach R; Tomaszewska R; Kulig J; Richter P; Sierzega M
    Pancreatology; 2018 Dec; 18(8):977-982. PubMed ID: 30268674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of mucin expression in pancreatobiliary neoplasms.
    Yonezawa S; Higashi M; Yamada N; Yokoyama S; Goto M
    J Hepatobiliary Pancreat Sci; 2010 Mar; 17(2):108-24. PubMed ID: 19787286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.
    Yamaguchi J; Mino-Kenudson M; Liss AS; Chowdhury S; Wang TC; Fernández-Del Castillo C; Lillemoe KD; Warshaw AL; Thayer SP
    Gastroenterology; 2016 Dec; 151(6):1232-1244.e10. PubMed ID: 27523981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness.
    Ganguly K; Krishn SR; Rachagani S; Jahan R; Shah A; Nallasamy P; Rauth S; Atri P; Cox JL; Pothuraju R; Smith LM; Ayala S; Evans C; Ponnusamy MP; Kumar S; Kaur S; Batra SK
    Cancer Res; 2021 Jan; 81(1):91-102. PubMed ID: 33127746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas.
    Kim GE; Bae HI; Park HU; Kuan SF; Crawley SC; Ho JJ; Kim YS
    Gastroenterology; 2002 Oct; 123(4):1052-60. PubMed ID: 12360467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.
    Andrianifahanana M; Moniaux N; Schmied BM; Ringel J; Friess H; Hollingsworth MA; Büchler MW; Aubert JP; Batra SK
    Clin Cancer Res; 2001 Dec; 7(12):4033-40. PubMed ID: 11751498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semiquantitative immunohistochemistry for mucin (MUC1, MUC2, MUC3, MUC4, MUC5AC, and MUC6) profiling of pancreatic ductal cell adenocarcinoma improves diagnostic and prognostic performance.
    Sierzega M; Młynarski D; Tomaszewska R; Kulig J
    Histopathology; 2016 Oct; 69(4):582-91. PubMed ID: 27165582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy.
    Torres MP; Rachagani S; Souchek JJ; Mallya K; Johansson SL; Batra SK
    PLoS One; 2013; 8(11):e80580. PubMed ID: 24278292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.
    Remmers N; Anderson JM; Linde EM; DiMaio DJ; Lazenby AJ; Wandall HH; Mandel U; Clausen H; Yu F; Hollingsworth MA
    Clin Cancer Res; 2013 Apr; 19(8):1981-93. PubMed ID: 23446997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucin-based targeted pancreatic cancer therapy.
    Torres MP; Chakraborty S; Souchek J; Batra SK
    Curr Pharm Des; 2012; 18(17):2472-81. PubMed ID: 22372499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic KRAS, Mucin 4, and Activin A-Mediated Fibroblast Activation Cooperate for PanIN Initiation.
    Hu CM; Huang CC; Hsu MF; Chien HJ; Wu PJ; Chen YI; Jeng YM; Tang SC; Chung MH; Shen CN; Chang MC; Chang YT; Tien YW; Lee WH
    Adv Sci (Weinh); 2023 Dec; 10(36):e2301240. PubMed ID: 37964407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model.
    Rachagani S; Macha MA; Menning MS; Dey P; Pai P; Smith LM; Mo YY; Batra SK
    Oncotarget; 2015 Nov; 6(37):40295-309. PubMed ID: 26516699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical study of the association between the progression of pancreatic ductal lesions and the expression of MUC1, MUC2, MUC5AC, and E-cadherin.
    Kigure S
    Rinsho Byori; 2006 May; 54(5):447-52. PubMed ID: 16789413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury.
    Fendrich V; Jendryschek F; Beeck S; Albers M; Lauth M; Esni F; Heeger K; Dengler J; Slater EP; Holler JPN; Baier A; Bartsch DK; Waldmann J
    Oncogene; 2018 Apr; 37(14):1845-1856. PubMed ID: 29367759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucin Expression and Splicing Determine Novel Subtypes and Patient Mortality in Pancreatic Ductal Adenocarcinoma.
    Thompson CM; Cannon A; West S; Ghersi D; Atri P; Bhatia R; Smith L; Rachagani S; Wichman C; Kumar S; Batra SK
    Clin Cancer Res; 2021 Dec; 27(24):6787-6799. PubMed ID: 34615717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.